Cargando…
Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
Diabetic nephropathy is characterised by the excessive amount of extracellular matrix in glomeruli and tubulointerstitial space. Lysyl oxidase-like 2 (LOXL2) is elevated in renal fibrosis and known to play key roles in ECM stabilisation by facilitating collagen cross-links, epithelial to mesenchymal...
Autores principales: | Stangenberg, Stefanie, Saad, Sonia, Schilter, Heidi C., Zaky, Amgad, Gill, Anthony, Pollock, Carol A., Wong, Muh Geot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013429/ https://www.ncbi.nlm.nih.gov/pubmed/29930330 http://dx.doi.org/10.1038/s41598-018-27462-6 |
Ejemplares similares
-
Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy
por: Wong, May YW, et al.
Publicado: (2020) -
Lysyl oxidase inhibitors attenuate cyclosporin A-induced nephropathy in mouse
por: Nguyen, Long T., et al.
Publicado: (2021) -
FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity
por: Glastras, Sarah J., et al.
Publicado: (2015) -
The Impact of Maternal Cigarette Smoke Exposure in a Rodent Model on Renal Development in the Offspring
por: Al-Odat, Ibrahim, et al.
Publicado: (2014) -
The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis
por: Schilter, Heidi, et al.
Publicado: (2018)